OBJECTIVE To investigate the usage of antimicrobial in outpatients with laboratory-confirmed influenza in a children′s hospital during the flu season, and to provide evidence for scientific antimicrobial stewardship. METHODS During the 2017-2018 flu season, medical records of laboratory-confirmed influenza positive cases in our hospital were reviewed to collect information including prescription of antimicrobial, laboratory data; and the rationality of the use of antimicrobial was evaluated based on clinical diagnosis. Logistic regression was used to establish the prediction model of antimicrobial usage, which was used to test the factors affecting usage of antimicrobial in outpatients with influenza infections. RESULTS Among 201 confirmed-influenza cases, 107 (53.2%) were prescribed antimicrobial (at least one drug), and 92 (86.0%) were treated irrationally. In most patients, macrolides and the third generation of cephalosporins were used; and the most frequently used antimicrobials were azithromycin, cefixime and clarithromycin. According to the prediction model, the use of antimicrobial was significantly associated with abnormal C-reactive protein (CRP) level in children (adjusted OR=4.697; 95%CI: 2.187-10.090) and negative results of rapid influenza diagnostic test (RIDT) (adjusted OR=2.228; 95%CI:1.058-4.692); age, onset season, use of anti-influenza virus drugs, white blood cell counting, proportion of neutrophils, RIDT positive results, a clinical diagnosis of influenza and influenza typing were not risk factors. CONCLUSION The rate of antimicrobial usage in out patients with in fluenza is high, and the management department should take targeted measures to reduce the unreasonable use of antimicrobial.
蔡志波, 梁建凤, 林艳, 黄梦珊. 某大型儿童医院门诊流感患者抗菌药物使用情况回顾性分析[J]. 中国药学杂志, 2019, 54(16): 1336-1342.
CAI Zhi-bo, LIANG Jian-feng, LIN Yan, HUANG Meng-shan. Antimicrobial Prescribing for Outpatients with Laboratory-confirmed Influenza in a Large Children′s Hospital: A Retrospective Study. Chinese Pharmaceutical Journal, 2019, 54(16): 1336-1342.
NEUZIL K M, MELLEN B G, WRIGHT P F, et al. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med, 2000, 342(4):225-231.
IULIANO A D, ROGUSKI K, CHANG H H, et al. Estimates of global seasonal influenza-associated respiratory mortality: a modeling study. Lancet, 2017, 391(10127):1285-1300.
COMMITTEE ON INFECTIOUS DISEASES. Recommendations for prevention and control of influenza in children, 2017-2018. Pediatrics, 2017, 140(4):e20172550.
LOW D. Reducing antibiotic use in influenza: challenges and rewards. Clin Microbiol Infect,2008,14(4):298-306.
FRIEDMAN B, SCHWABEWARF D, GOLDMAN R D, et al. Reducing inappropriate antibiotic use among children with influenza infection. Can Fam Physician, 2011, 57(1):42-44.
HAVERS F P, HICKS L A, CHUNG J R, et al. Outpatient antibiotic prescribing foracute respiratory infections during influenza seasons. JAMA Netw Open,2018,1(2):e180243.
WANG K, CARVER T, TONNER S, et al. Early use of antibiotics for at risk children with influEnza (ARCHIE): protocol for a double-blind, randomised, placebo-controlled trial. BMJ Open, 2018, 8(5):e021144.
BRITISH INFECTION SOCIETY, BRITISH THORACIC SOCIETY, HEALTHPROTECTION AGENCY. Pandemic flu: clinical management of patients with an influenza-like illness during an influenza pandemic. Thorax, 2007, 62(suppl 1):1-46.
RESPIRATORY GROUP, CHINESE ACADEMY OFPEDIATRICS. Expert consensus on diagnosis and treatment of childhood influenza(2015 edition).Chin Appl Clin Pediatr(中华实用儿科临床杂志),2015,30(17):1296-1303.
MISURSKI D A, LIPSON D A, CHANGOLKAR A K, et al. Inappropriate antibiotic prescribing in managed care subjects with influenza. Am J Manag Care, 2011, 17(9):601-608.
CAO B, LI R, LIU Y M, et al. The impact of antibiotic treatment in patients with influenza like illness. Chin J Tuberc Respir Dis(中华结核和呼吸杂志),2008, 31(7):483-487.
CARRAT F, SCHWARZINGER M, HOUSSET B, et al. Antibiotic treatment for influenza does not affect resolution of illness, secondary visits or lost workdays. Eur J Epidemiol, 2004,19(7):703-705.
WANG X J, CUI J Y, ZHOU X. Clinical investigation and antibiotic treatment in 394 cases of school-age children with influenza-like illness. Chin J Exp Clin Infect Dis(Electron Ed)(中华实验和临床感染病杂志:电子版),2016,10(2):240-243.
MEIER C R, NAPALKOV P N, EGMLLER Y W, et al. Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the united kingdom. Eur J Clin Microbiol Infect Dis, 2000, 19(11):834-842.
KLEIN E Y, MONTEFORTE B, GUPTA A, et al. The frequency of influenza and bacterial coinfection:a systematic review and Meta-analysis. Influenza Other Respir Viruses, 2016, 10(5): 394-403.
TILLEKERATNE L G, BODINAYAKE C K, NAGAHAWATTE A, et al. Use of rapid influenzatesting to reduce antibiotic prescriptions among outpatients with influenza-like illness in southern sri lanka. Am J Trop Med Hyg, 2015, 93(5):1031-1037.
WANG X Y, KILGORE P E, LIM K A. Influenza and bacterial pathogen coinfections in the 20th century. Interdiscip Perspect Infect Dis, 2011:146376. doi:10.1155/2011/146376.
FUPIN H U, GUO Y, ZHU D, et al. CHINET surveillance of bacterial resistance across China:report of the results in 2016. Chin J Infect Chemother(中国抗感染化疗杂志), 2017, 17(5):481-491.
HERSH A L, JACKSON M A, HICKS L A . Principles of judicious antibiotic prescribing for upper respiratory tract infections in pediatrics. Pediatrics, 2013, 132(6):1146-1154.
OVETCHKINE P, RIEDER M J. Azithromycin use in paediatrics: a practical overview. Paediatr Child Health, 2013,18(6):311-316.
BRADLEY J S, BYINGTON C L, SHAH S S, et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the pediatric infectious diseases society and the infectious diseases society of america. Clin Infect Dis, 2011, 53(7):617-630.
KWONG J C, MAATEN S, UPSHUR R E, et al. The effect of universal influenza immunization on antibiotic prescriptions: an ecological study. Clin Infect Dis, 2009, 49(5): 750-756.
GLASZIOU P. Delayed antibiotics reduced antibiotic use in acute respiratory infection without increasing symptom duration. Anna Inter Med, 2016, 164(10):JC50.
SPURLING G K, DELMAR C B, DOOLEY L, et al. Delayed antibiotic prescriptions for respiratory infections. Cochrane Database Syst Rev, doi:10.1002/14651858.CD004417.pub5.